KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CATB
Delisted

Catabasis Pharmaceuticals Stock Price (Quote)

$3.36
+0.195 (+6.16%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $3.02 $6.17 Friday, 27th May 2022 CATB stock ended at $3.36. This is 6.16% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 6.65% from a day low at $3.16 to a day high of $3.37.
90 days $3.02 $7.25
52 weeks $1.20 $10.26

Historical Catabasis Pharmaceuticals prices

Date Open High Low Close Volume
Aug 12, 2021 $1.43 $1.43 $1.35 $1.36 526 391
Aug 11, 2021 $1.35 $1.43 $1.31 $1.39 569 991
Aug 10, 2021 $1.43 $1.45 $1.29 $1.37 1 747 409
Aug 09, 2021 $1.55 $1.60 $1.53 $1.56 213 873
Aug 06, 2021 $1.53 $1.56 $1.50 $1.55 199 697
Aug 05, 2021 $1.53 $1.54 $1.46 $1.52 228 360
Aug 04, 2021 $1.53 $1.55 $1.48 $1.50 306 527
Aug 03, 2021 $1.63 $1.66 $1.46 $1.51 932 008
Aug 02, 2021 $1.63 $1.68 $1.61 $1.64 199 962
Jul 30, 2021 $1.66 $1.68 $1.63 $1.63 197 544
Jul 29, 2021 $1.71 $1.73 $1.62 $1.66 380 756
Jul 28, 2021 $1.66 $1.72 $1.65 $1.72 247 963
Jul 27, 2021 $1.61 $1.68 $1.54 $1.67 698 360
Jul 26, 2021 $1.62 $1.66 $1.60 $1.63 244 531
Jul 23, 2021 $1.65 $1.66 $1.62 $1.63 398 613
Jul 22, 2021 $1.72 $1.73 $1.64 $1.66 285 413
Jul 21, 2021 $1.79 $1.80 $1.68 $1.69 586 606
Jul 20, 2021 $1.65 $1.82 $1.65 $1.80 613 227
Jul 19, 2021 $1.62 $1.70 $1.58 $1.64 758 863
Jul 16, 2021 $1.68 $1.80 $1.64 $1.65 986 703
Jul 15, 2021 $1.73 $1.75 $1.65 $1.67 541 702
Jul 14, 2021 $1.84 $1.86 $1.72 $1.73 493 046
Jul 13, 2021 $1.96 $1.99 $1.81 $1.82 4 185 240
Jul 12, 2021 $2.02 $2.03 $1.96 $1.98 235 921
Jul 09, 2021 $2.02 $2.03 $1.96 $2.01 378 056
Click to get the best stock tips daily for free!

About Catabasis Pharmaceuticals

Catabasis Pharmaceuticals Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat inflammatory and metabolic diseases. Its product pipeline includes CAT-1004, an oral small molecule that has completed Phase 1 clinical trials for the treatment of duchenne muscular dystrophy (DMD); CAT-2054, which is in Phase I clinical trial for the treatment of hypercholesterolemia i... CATB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT